New Key Statistics Module, Z-Score and F-Score
TSX:GUD Key Ratios
Market Cap C$ M | 608.26 |
Enterprise Value C$ M | 486.10 |
P/E(ttm) | -- |
PE Ratio without NRI | 58.25 |
Forward PE Ratio | 200.00 |
Price/Book | 0.80 |
Price/Sales | 1.90 |
Price/Free Cash Flow | 12.55 |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) C$ M | 332.00 |
EPS (TTM) C$ | -0.16 |
Beneish M-Score | -2.86 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.00 |
y-y EBITDA Growth Rate % | -8.00 |
EV-to-EBIT | -40.81 |
EV-to-EBITDA | 12.80 |
PEG | 6.47 |
Shares Outstanding M | 101.38 |
Net Margin (%) | -5.25 |
Operating Margin % | 1.02 |
Pre-tax Margin (%) | -7.28 |
Quick Ratio | 2.52 |
Current Ratio | 3.33 |
ROA % (ttm) | -1.75 |
ROE % (ttm) | -2.21 |
ROIC % (ttm) | 0.34 |
Dividend Yield % | -- |
Altman Z-Score | 2.62 |
TSX:GUD Number of Guru Trades
TSX:GUD Volume of Guru Trades
Gurus Latest Trades with TSX:GUD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSX:GUD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Knight Therapeutics Inc Insider Transactions
No Available Data